Casdin Capital, LLC

13F Portfolio Filings

Most recent 13F
Q3 2026
Location
New York, NY
CIK
0001534261
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2026 48 2,295,707 RVMD, RLAY, WGS, BLFS 13F-HR 11/16/2026 000091957426008113
Q2 2026 43 1,997,799 RVMD, RLAY, WGS, BLFS 13F-HR 8/14/2026 000091957426005491
Q1 2026 40 1,320,592 RVMD, WGS, RLAY, BLFS 13F-HR 5/15/2026 000091957426003451
Q4 2025 38 1,609,916 WGS, RVMD, BLFS, LAB 13F-HR 2/17/2026 000091957426001181
Q3 2025 32 1,199,325 WGS, BLFS, RVMD, LAB 13F-HR 11/14/2025 000091957425007006
Q2 2025 33 1,098,158 WGS, BLFS, RVMD, LAB 13F-HR 8/14/2025 000091957425004903
Q1 2025 44 1,223,806 WGS, BLFS, RVMD, LAB 13F-HR 5/15/2025 000091957425003248
Q4 2024 39 1,495,471 WGS, BLFS, RVMD, SRPT 13F-HR 2/14/2025 000091957425001518
Q3 2024 35 1,499,957 BLFS, RVMD, WGS, LAB 13F-HR 11/14/2024 000091957424006736
Q2 2024 38 1,309,655 BLFS, RVMD, SRPT, LAB RESTATEMENT 10/18/2024 000091957424005948
Q1 2024 37 1,343,816 RVMD, LAB, BLFS, SRPT 13F-HR 5/15/2024 000091957424003198
Q4 2023 38 1,014,239 RVMD, BLFS, SRPT, RLAY 13F-HR 2/14/2024 000091957424001474
Q3 2023 40 896,552 SRPT, BLFS, EQRX, GPCR 13F-HR 11/14/2023 000091957423006405
Q2 2023 41 1,144,295 BLFS, SRPT, RLAY, EQRX 13F-HR 8/14/2023 000091957423004796
Q1 2023 41 1,210,553 BLFS, SRPT, RLAY, EQRX 13F-HR 5/15/2023 000091957423003310
Q4 2022 46 1,280,741 SRPT, BLFS, EQRX, ALNY 13F-HR 2/14/2023 000091957423001552
Q3 2022 37 1,515,354 EQRX, BLFS, SRPT, ALNY 13F-HR 11/14/2022 000091957422006773
Q2 2022 40 1,182,711 EQRX, ALNY, BLFS, RLAY 13F-HR 8/15/2022 000091957422005034
Q1 2022 47 2,230,233 BLFS, ALNY, EQRX, FATE 13F-HR 5/16/2022 000153426122000004
Q4 2021 53 3,548,006 BLFS, EQRX, FATE, NVTAQ 13F-HR 2/14/2022 000153426122000002
Q3 2021 54 4,008,437 NVTAQ, BLFS, EXAS, PACB 13F-HR 11/15/2021 000153426121000008
Q2 2021 54 3,939,403 NVTAQ, BLFS, FATE, EXAS 13F-HR 8/16/2021 000153426121000006
Q1 2021 48 3,357,621 NVTAQ, EXAS, FATE, BLFS 13F-HR 5/17/2021 000153426121000004
Q4 2020 52 3,360,910 NVTAQ, BLFS, FATE, EXAS 13F-HR 2/16/2021 000153426121000002
Q3 2020 45 2,233,335 NVTAQ, BLFS, RLAY, BPMC 13F-HR 11/16/2020 000153426120000014
Q2 2020 42 1,689,747 NVTAQ, BPMC, FATE, SRPT 13F-HR 8/14/2020 000153426120000012
Q1 2020 38 942,016 BPMC, SRPT, ALNY, FATE 13F-HR 5/15/2020 000153426120000008
Q4 2019 32 1,074,421 SRPT, BLUE, CDXS, BPMC 13F-HR 2/14/2020 000153426120000005
Q3 2019 33 966,301 ONCE, NVTAQ, CDXS, BPMC RESTATEMENT 1/3/2020 000153426120000001
Q2 2019 31 1,068,382 ONCE, NVTAQ, BPMC, CDXS 13F-HR 8/13/2019 000153426119000010
Q1 2019 29 910,374 ONCE, BPMC, MYOK, SAGE 13F-HR 5/15/2019 000153426119000008
Q4 2018 31 584,510 LOXO, MYOK, BPMC, CDXS 13F-HR 2/13/2019 000153426119000007
Q3 2018 36 814,429 LOXO, BPMC, MYOK, AGIO 13F-HR 11/14/2018 000117266118002093
Q2 2018 35 708,660 FMI, LOXO, BPMC, SAGE RESTATEMENT 8/20/2018 000117266118001712
Q1 2018 31 565,044 LOXO, FMI, SAGE, BPMC 13F-HR 5/15/2018 000117266118001199
Q4 2017 27 409,206 SAGE, FMI, LOXO, BPMC 13F-HR 2/14/2018 000117266118000559
Q3 2017 26 354,153 LOXO, MYOK, ALNY, SGMOQ 13F-HR 11/14/2017 000117266117002006
Q2 2017 35 250,031 LOXO, SAGE, FMI, BPMC 13F-HR 8/14/2017 000117266117001658
Q1 2017 29 169,512 SAGE, FMI, LOXO, AGIO 13F-HR 5/15/2017 000117266117001193
Q4 2016 25 121,078 SAGE, LOXO, AGIO, FMI 13F-HR 2/14/2017 000117266117000699
Q3 2016 26 123,498 AGIO, SAGE, FMI, EVH 13F-HR 11/14/2016 000117266116004290
Q2 2016 27 95,695 ONCE, AGIO, FMI, GBT 13F-HR 8/15/2016 000117266116003861
Q1 2016 26 84,542 LOXO, EPZM, FMI, SAGE 13F-HR 5/9/2016 000117266116003186
Q4 2015 31 107,415 BPMC, SAGE, LOXO, CTMX 13F-HR 2/8/2016 000117266116002454
Additional filings from Casdin Capital, LLC that have since been restated

13D and 13G Filings

All 13D and 13G filings

Each security where the latest filing since 12/18/2024 is a 13D, newest first.

Issuer % of Class Filed
Standard BioTools Inc. 13D/A
LAB · 34385P108
23.9% 6/9/2026
Event 6/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Tenaya Therapeutics, Inc. 13D/A
TNYA · 87990A106
4.3% 3/7/2025
Event 3/4/2025

5 other securities where the latest filing is a 13G, the newest filed 6/4/2026. View all